What semaglutide does to your teeth — and what the evidence says

No direct causal link between semaglutide and tooth damage has been established in clinical trials or regulatory guidance as of 2026.
Nausea, vomiting and dry mouth are known gastrointestinal side effects of semaglutide that can indirectly affect oral health.
Reduced appetite and faster satiety may lower food and drink intake, which can contribute to dry mouth and changes in saliva flow.
The MHRA and NHS both advise reporting any unexpected side effects, including oral symptoms, via the Yellow Card scheme at yellowcard.mhra.gov.uk.

There is no established, direct link between semaglutide and tooth decay or gum disease — but people starting Wegovy do sometimes notice changes in their mouth, and those changes have real, traceable causes worth understanding. If you have been googling about semaglutide and teeth because something feels different since you started treatment, that instinct to look it up is a sensible one. Semaglutide is a prescription-only medicine, and any new symptoms are worth raising with a clinician or your dentist.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How semaglutide treatment can affect oral health, step by step

Step 1: What happens in the mouth during the early weeks of treatment

Most people beginning Wegovy go through an adjustment phase. The most common side effects are gastrointestinal (nausea, vomiting, reflux) and the full semaglutide prescribing information documents these thoroughly. For your teeth, the relevant consequence is stomach acid. Frequent nausea or vomiting brings acid into the mouth repeatedly, and acid exposure is one of the most established causes of dental erosion there is. This is not a semaglutide-specific problem; it is the same mechanism seen in other conditions involving repeated vomiting. It does not happen to everyone, and for many people the GI symptoms settle within a few weeks.

Dry mouth is the other early factor. Semaglutide slows gastric emptying and reduces hunger, which often means people eat and drink less than before. Saliva production is partly stimulated by chewing and swallowing, so eating less frequently can reduce salivary flow. Saliva is your mouth's natural defence against bacteria and acid, it buffers pH, washes away food debris and remineralises enamel. Less of it creates conditions where plaque and early decay can take hold more quickly than usual.

If you are in this phase and worried about Wegovy-related teeth issues, the practical message is simple: rinse with water after any episode of nausea or vomiting rather than brushing immediately (brushing softened enamel adds abrasion), stay well hydrated, and mention it at your next dental appointment.

Step 2: Appetite changes and what they mean for diet-related tooth risk

One of the ways semaglutide works is by making food feel less urgent. That is the point. But the foods and drinks people reach for less often (or more often) once appetite shifts can matter to dental health. Sugary or acidic snacks grazed throughout the day are a significant driver of decay; eating less frequently actually reduces acid challenge cycles on enamel. In this respect, eating fewer meals or snacks on treatment may be neutral or even marginally beneficial for teeth compared with frequent snacking before treatment.

The risk runs the other way for soft drinks. If reduced appetite means swapping meals for frequent small sips of fizzy drinks, squash or fruit juice to manage hunger or nausea, acid and sugar exposure can increase. Sipping acidic drinks slowly over time is harder on enamel than drinking water. Plain water, milk or diluted drinks are better choices throughout treatment. The broader picture of managing side effects on Wegovy often comes down to simple practical habits like this.

There is nothing in the semaglutide SmPC or the published STEP trial programme that identifies tooth damage as a direct pharmacological effect of the drug itself. The NHS medicines page on semaglutide lists common and uncommon side effects in detail; oral or dental symptoms are not among them as direct effects.

Step 3: Existing data, what is being watched, and what to tell your dentist

Post-marketing surveillance of GLP-1 medicines is ongoing. The MHRA actively collects Yellow Card reports from patients and clinicians, and any signal connecting semaglutide to dental harm at a population level would be expected to emerge through that process. So far, no such signal has been formally identified in UK regulatory communications. If you notice something unexpected involving your gums or teeth during treatment, reporting it via the MHRA's Yellow Card scheme is genuinely useful, not just bureaucracy. It is how drug safety is monitored in real-world use.

Tell your dentist you are taking semaglutide at your next check-up. That context helps them interpret what they see. If you are experiencing frequent nausea, they may recommend a higher-fluoride toothpaste or a prescription fluoride gel. They may also want to look at saliva function if dry mouth is persistent. These are standard responses to acid erosion risk; they are not alarming, just sensible.

There is also a more specific question about tooth pain during Wegovy treatment that some people report, this is explored in detail separately, including the distinction between referred discomfort and direct dental symptoms. And for those thinking about whether treatment is right for them, our prescribers are available for a free consultation; semaglutide is a prescription-only medicine reviewed on clinical grounds, and oral health history is part of the picture a prescriber considers.

For a thorough grounding in whether semaglutide directly affects teeth at a pharmacological level, that question is addressed in more depth in a dedicated piece. The short version: current evidence points to indirect effects via GI symptoms and appetite changes, not a direct drug-to-enamel mechanism. That distinction matters, because the indirect effects are manageable with good dental hygiene, hydration and a conversation with your dentist.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions